(Q42490827)

1 November 2017

Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells (English)

1 reference

1 November 2017

Noriko Yumoto

1

1 reference

1 November 2017

Xiaomei Yu

series ordinal

2

1 reference

1 November 2017

Mariko Hatakeyama

series ordinal

3

1 reference

1 November 2017

language of work or name

1 reference

14 February 2006

1 reference

Molecular and Cellular Biochemistry

1 November 2017

1 reference

1 November 2017

285

1 reference

1 November 2017

1-2

1 reference

1 November 2017

165-171

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-005-9075-5

1 November 2017

0 references

cites work

Chimeric receptor analyses of the interactions of the ectodomains of ErbB-1 with epidermal growth factor and of those of ErbB-4 with neuregulin

1 reference

12 December 2020

Tissue expression of neu differentiation factor/heregulin and its receptor complex in prostate cancer and its biologic effects on prostate cancer cells in vitro

1 reference

12 December 2020

Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes

1 reference

12 December 2020

Regulation of Raf-1 activation and signalling by dephosphorylation

1 reference

12 December 2020

Comparative analysis of the EGF-receptor family in pancreatic cancer: expression of HER-4 correlates with a favourable tumor stage.

1 reference

12 December 2020

Heregulin-dependent Trafficking and Cleavage of ErbB-4

1 reference

12 December 2020

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

12 December 2020

RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251.

1 reference

12 December 2020

Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells

1 reference

12 December 2020

The ErbB signaling network: receptor heterodimerization in development and cancer

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase

1 reference

12 December 2020

Elevation of cyclic adenosine 3',5'-monophosphate potentiates activation of mitogen-activated protein kinase by growth factors in LNCaP prostate cancer cells

1 reference

12 December 2020

Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling

1 reference

12 December 2020

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma

1 reference

12 December 2020

Shc isoform-specific tyrosine phosphorylation by the insulin and epidermal growth factor receptors

1 reference

12 December 2020

Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

The function of GRB2 in linking the insulin receptor to Ras signaling pathways

1 reference

12 December 2020

Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism.

1 reference

12 December 2020

The specificity of extracellular signal-regulated kinase 2 dephosphorylation by protein phosphatases

1 reference

12 December 2020

Serine/threonine phosphorylation of ShcA. Regulation of protein-tyrosine phosphatase-pest binding and involvement in insulin signaling.

1 reference

12 December 2020

Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction

1 reference

12 December 2020

Protein phosphatases and the regulation of mitogen-activated protein kinase signalling.

1 reference

12 December 2020

Tyr-317 phosphorylation increases Shc structural rigidity and reduces coupling of domain motions remote from the phosphorylation site as revealed by molecular dynamics simulations.

1 reference

12 December 2020

Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A.

1 reference

12 December 2020

Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK

1 reference

12 December 2020

Integrin alpha 2 beta 1 promotes activation of protein phosphatase 2A and dephosphorylation of Akt and glycogen synthase kinase 3 beta.

1 reference

12 December 2020

10.1007/S11010-005-9075-5

Identifiers

DOI

1 reference

1 November 2017

1 reference